Seladelpar as an Alternate Second-Line Agent for Primary Biliary Cirrhosis

Gastroenterology. 2024 Oct;167(5):1047. doi: 10.1053/j.gastro.2024.06.009. Epub 2024 Jun 20.
No abstract available

MeSH terms

  • Humans
  • Liver Cirrhosis, Biliary* / drug therapy
  • Treatment Outcome